Compare SMX Security Matters plc (SMX) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SMX Security Matters plc vs BIO-TECHNE Corp — how do they compare? SMX Security Matters plc trades at $20.36 (market cap $16.38M), while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: BIO-TECHNE Corp is far larger — about 681.3× SMX Security Matters plc's market cap, and BIO-TECHNE Corp pays a 0.45% dividend while SMX Security Matters plc pays none. Which is the better fit depends on your goals.
| SMX | TECH | |
|---|---|---|
Market Cap | $16.38M | $11.16B |
Sector | Technology | Health |
52-Week High | $295.56K | $72.12 |
52-Week Low | $12.87 | $43.31 |
Enterprise Value | $13.35M | $11.24B |
Dividend Yield | — | 0.45% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SMX trades at $17.66, up 6.9% today, with neutral technical signals and bearish moving averages. The stock shows a P/B of 1.85 but negative profitability metrics, including a -2,216.26% ROE. Recent news highlights balance sheet strengthening and commercialization progress in recycled materials tracking technology, amid regulatory tailwinds for verified plastics.
Outlook hinges on execution of global strategy and policy-driven demand, but high financial losses and reverse stock splits signal substantial risk. Investor sentiment is cautious despite positive media coverage on industry positioning.
Bio-Techne (TECH) trades at $71.64, down 0.67% today, near its 52-week high following Merck KGaA's $73 per share acquisition offer. The stock shows bullish technical signals with strong moving averages, though RSI indicates overbought conditions. Recent earnings have been mixed, with Q4 2025 beating expectations but Q1 2026 missing. The company maintains solid gross margins of 64.96% but faces declining net income margins, down to 6.01% in 2025 from 25.09% in 2023.
The outlook is heavily influenced by the pending acquisition, offering a clear exit near current levels. Risks include shareholder litigation over deal fairness and fundamental profitability pressures. With a high P/E of 103.03, the stock's upside appears capped without the deal, while the $73 bid provides a near-term floor. Investors should weigh acquisition completion probability against operational challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About SMX Security Matters plc
SMX Security Matters plc is a digital authentication and tracking technology company that uses a chemical-based, invisible marker system to trace and verify products across global supply chains. Their technology creates a 'digital twin' of physical products, used for quality control, counterfeiting prevention, and ensuring sustainability compliance from raw materials to final sale. The company's solutions are applied across various industries, including precious materials, luxury goods, and fast-moving consumer goods.
Read more on SMX →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
